Atherosclerosis
Volume 146, Issue 1 , Pages 133-140 , September 1999

Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population

  • Xing L Wang

      Affiliations

    • Department of Cardiovascular Medicine, University of New South Wales, Prince Henry/Prince of Wales Hospitals, Sydney, Australia
    • Corresponding Author InformationCorresponding author. Present address: Cardiovascular Genetics Laboratory, Ground Floor, Edmund Blacket Building, Prince of Wales Hospital, Randwick, NSW 2031, Australia. Tel.: +61-2-93824835; fax: +61-2-93824826
    • ,
  • Natalia Duarte

      Affiliations

    • Department of Cardiovascular Medicine, University of New South Wales, Prince Henry/Prince of Wales Hospitals, Sydney, Australia
    • ,
  • Hua Cai

      Affiliations

    • Department of Cardiovascular Medicine, University of New South Wales, Prince Henry/Prince of Wales Hospitals, Sydney, Australia
    • ,
  • Tetsuo Adachi

      Affiliations

    • Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University, 5-6-1 Mitahora-higashi, Gifu, Japan
    • ,
  • Ah Siew Sim

      Affiliations

    • Department of Cardiovascular Medicine, University of New South Wales, Prince Henry/Prince of Wales Hospitals, Sydney, Australia
    • ,
  • Greg Cranney

      Affiliations

    • Department of Cardiovascular Medicine, University of New South Wales, Prince Henry/Prince of Wales Hospitals, Sydney, Australia
    • ,
  • David E.L Wilcken

      Affiliations

    • Department of Cardiovascular Medicine, University of New South Wales, Prince Henry/Prince of Wales Hospitals, Sydney, Australia

Received 13 October 1998 ,Revised 17 February 1999 ,Accepted 23 February 1999.

References 

  1. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest. 1976;57:1079–1082
  2. Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease: its occurrence, cofactor therapy and enzymology. Arterioscler Thromb. 1993;13:1253–1260
  3. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149–1155
  4. Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson PWF, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–291
  5. Boers GHJ, Smals AHG, Trijbels FJM, Trijbels FTM, Bakkeren TATM, Schoonderwaldt HC, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. New Engl J Med. 1985;313:709–715
  6. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al  Plasma homocysteine as a risk factor for vascular disease. The European concerted action project. JAMA. 1997;277:1775–1781
  7. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. New Engl J Med. 1997;337:230–236
  8. den Heiher M, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?. Lancet. 1995;345:882–885
  9. Wilcken DEL, Gupta VJ. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. Europ J Clin Invest. 1979;9:301–307
  10. Wilcken DEL, Gupta VJ, Betts AK. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin Sci. 1981;61:743–749
  11. Wilcken DEL, Dudman NPB, Tyrrell PA, Robertson MR. Folic acid lowers elevated plasma homocyst(e)ine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism. 1988;37:697–701
  12. Robinson K, Gupta A, Dennis V, Arheart K, Chaudhary D, Green R, et al. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation. 1996;94:2743–2748
  13. Wilcken DEL, Dudman NPB. Mechanisms of thrombogenesis and accelerated atherogenesis in homocysteinaemia. Haemostasis. 1989;19:14–23(supp. 1)
  14. Clarke R, Naughten E, Cahalane S, Sullivan KO, Mathias P, McCall T, et al. The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia. Ir J Med Sci. 1992;161:561–564
  15. Qutinen PA, Sood SK, Liaw PC, Sarge KD, Maeda N, Hirsh J, et al. Characterization of the stress-inducing effects of homocysteine. Biochem J. 1998;332:213–221
  16. Tsai J-C, Perrella MA, Yoshizumi M, Hsich CM, Haber E, Schlegel R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA. 1994;91:6369–6373
  17. Dalton ML, Gadson Jr PF, Wrenn RW, Rosenquist TH. Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells. FASEB J. 1997;11:703–711
  18. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic Basis of Inherited Disease, 6th Edn. New York: McGraw-Hill, 1995: 1279–1326.
  19. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures. J Biol Chem. 1997;272:1935–1942
  20. Avramopoulos D, Cox T, Kraus JP, Chakravarti A, Antonarakis SE. Linkage mapping of the cystathionine β-synthase (CBS) gene on human chromosome 21 using a DNA polymorphism in the 3′ untranslated region. Hum Genet. 1993;90:566–568
  21. Chen LH, Liu M-L, Hwang H-H, Chen L-S, Korenberg J, Shane B. Human methionine synthase. cDNA cloning, gene localization, and expression. J Biol Chem. 1997;272:3628–3634
  22. Fowler B. Disorders of homocysteine metabolism. J Inher Metab Dis. 1997;20:270–285
  23. Goyette P, Sumner JS, Milos R, Duncan AMV, Rosenblatt DS, Mathews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994;7:195–200
  24. Kozich V, Kraus JP. Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine β-synthase deficiency. Hum Mut. 1992;1(2):113–123
  25. Goyette P, Forsst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet. 1995;56:1052–1059
  26. Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shih VE. Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet. 1993;2(11):1857–1860
  27. Kraus JP. Molecular basis of phenotype expression in homocystinuria. J Inher Metab Dis. 1994;17:383–390
  28. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113
  29. Kang SS, Passen EL, Ruggie N, Wong PW, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1993;88:1463–1469
  30. Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor Jr LM, et al. Common mutation in methylenentetrahydrofolate reductase. correlation with homocysteine metabolism and late-onset vascular disease. Circulation. 1996;94:3074–3078
  31. Brattström L, Wilcken DEL, Öhrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease—the results of a meta analysis. Circulation. 1998;98:2520–2526
  32. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 1996;94:2410–2416
  33. Wilcken DEL, Wang XL, Sim AS, McCredie RM. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol. 1996;16:878–882
  34. Verhoef P, Rimm EB, Hunter DJ, Chen J, Willett WC, Kelsey K, et al. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among US men. J Am Coll Cardiol. 1998;32:353–359
  35. Wilcken DEL, Wang XL, Wilcken B. Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine and coronary disease. Circulation. 1997;96:2738–2739
  36. Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ. High prevalence of a mutation in the cystathionine β-synthase gene. Am J Hum Genet. 1996;59:1262–1267
  37. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of cbIG complementation group of folate/cobalamin disorders. Hum Mol Genet. 1996;5:1867–1874
  38. Gulati S, Baker P, Li YN, Fowler B, Kruger W, Brody LC, et al. Defects in human methionine synthase in cbiG patients. Hum Mol Genet. 1996;5:1859–1865
  39. Wang XL, Tam C, McCredie RM, Wilcken DEL. Determinants of severity of coronary artery disease in Australian men and women. Circulation. 1994;89:1974–1981
  40. Adachi T, Ohta H, Yamada H, Futenma A, Kato K, Hirano K. Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin Chim Acta. 1992;212:89–102
  41. Wang XL, Adachi T, Sim AS, Wilcken DEL. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:1915–1921
  42. Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15:2031–2036
  43. Karlsson K, Marklund SL. Extracellular superoxide dismutase in the vascular system of mammals. Biochem J. 1988;255:223–228
  44. Sandstrom J, Karlsson K, Edlund T, Marklund SL. Heparin-affinity patterns and composition of extracellular-superoxide dismutase in human plasma and tissues. Biochem J. 1993;294:847–853
  45. Karlsson K, Sandstrom J, Edlund A, Edlund T, Marklund SL. Pharmacokinetics of extracellular-superoxide dismutase in the vascular system. Free Radic Biol Med. 1993;14:185–190
  46. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The atherosclerosis risk in communities (ARIC) study. Circulation. 1998;98:204–210
  47. Kuller LH, Evans RW. Homocysteine, vitamins, and cardiovascular disease. Circulation. 1998;98:196–199
  48. Wang XL, Cai H, Cranney GB, Wilcken DEL. The frequency of a common mutation of the methionine synthase gene in the Australian population and its relation to coronary artery disease. J Cardiovascular Risk. 1998;5:289–295

PII: S0021-9150(99)00111-2

Atherosclerosis
Volume 146, Issue 1 , Pages 133-140 , September 1999

Article Tools